Find and Pitch Jounalists, Get Your Story Covered

Tags: BioPharma, Daily, Health IT, MedCity Influencers

	Profile	Recent Articles on Subject
1	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: A reporter’s JPM notebook: a look ahead for biopharma VC investing - 14 days ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - 14 days ago PharmaVoice’s Crystal Ball: The industry’s AI future - 24 days ago 3 closely watched drugs that failed in the clinic - about 2 months ago The big rebrand: Why these 4 biopharmas changed their name this year - about 2 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 3 months ago 2024 PharmaVoice 100s: Trailblazers - 4 months ago Who’s winning in biotech’s tight market? - 5 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 5 months ago Is anyone taking the world’s priciest drugs? - 5 months ago Neuro drugs are still faltering, despite rising investment - 6 months ago Up-and-comers look for an edge in the bustling ADC field - 7 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 8 months ago Where competition is heating up in pharma - 8 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago PharmaVoice 100s: Entrepreneurs - about 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - 23 days ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	East Asians under-represented in biopharma leadership - 23 days ago BioMarin’s big day today - 5 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	A biotech’s race to tackle the most severe hepatitis - about 2 months ago Milk-based therapies could be coming. This biotech CEO is aiming to lead the way. - 2 months ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 6 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 6 months ago Behind the powerful computations, AI’s role in pharma is still beset by challenges - 8 months ago 4 offbeat biotechs making a splash in the life sciences - 9 months ago These biotech hotspots are ripe for IPOs - 11 months ago
6	John Wilkerson STAT News STAT Washington correspondent. Healthcare Journalism	STAT+: BIOSECURE Act, aimed at Chinese drug manufacturers, is dealt a major blow - about 2 months ago STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
7	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 months ago STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - about 1 year ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - about 1 year ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - about 1 year ago
8	Sarah Owermohle STAT News Health reporter @STATNews. Covers Biden's agenda. Washington, District of Columbia health policyjournalism	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
9	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: Pharma giant GSK is quitting BIO in latest setback for the lobbying group - 3 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 5 months ago Five Quick Facts to Know About Biosimilars - 6 months ago Key Market Trends for the Current Specialty Drug Pipeline - over 1 year ago

Journalists covering Biopharmaceuticals